Tirapazamine structure
|
Common Name | Tirapazamine | ||
---|---|---|---|---|
CAS Number | 27314-97-2 | Molecular Weight | 178.148 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | 493.6±28.0 °C at 760 mmHg | |
Molecular Formula | C7H6N4O2 | Melting Point | 220ºC | |
MSDS | Chinese USA | Flash Point | 252.3±24.0 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of TirapazamineTirapazamine is an anticancer agent that shows selective cytotoxicity for hypoxic cells in solid tumors, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. |
Name | tirapazamine |
---|---|
Synonym | More Synonyms |
Description | Tirapazamine is an anticancer agent that shows selective cytotoxicity for hypoxic cells in solid tumors, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. |
---|---|
Related Catalog | |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 493.6±28.0 °C at 760 mmHg |
Melting Point | 220ºC |
Molecular Formula | C7H6N4O2 |
Molecular Weight | 178.148 |
Flash Point | 252.3±24.0 °C |
Exact Mass | 178.049072 |
PSA | 89.83000 |
LogP | -0.31 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.777 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xi: Irritant; |
Risk Phrases | 36/37/38 |
Safety Phrases | 26-36 |
RIDADR | NONH for all modes of transport |
RTECS | DM0671500 |
Precursor 6 | |
---|---|
DownStream 3 | |
An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.
J. Biomed. Mater. Res. B. Appl. Biomater. 103(3) , 618-28, (2015) Three-dimensional (3-D) tissue engineered constructs provide a platform for examining how the local extracellular matrix contributes to the malignancy of various cancers, including human glioblastoma ... |
|
Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels.
Oxid. Med. Cell. Longev. 2012 , 890826, (2012) Doxorubicin (DOX) causes long-term cardiomyopathy that is dependent on oxidative stress and contractility disorders. Tirapazamine (TP), an experimental adjuvant drug, passes the same red-ox transforma... |
|
Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
Br. J. Cancer 77 Suppl 4 , 12-4, (1998) Human solid tumours are composed of a significant proportion of hypoxic cells, i.e. cells with oxygen levels lower than those of normal tissues. Tumour hypoxic cells have been shown to have a negative... |
4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine |
1,2,4-Benzotriazin-3-amine, 1,4-dioxide |
3-Amino-1,2,4-benzotriazine 1,4-Dioxide |
1,4-Dioxido-1,2,4-benzotriazin-3-ylamine |
SR 259075 |
1,2,4-Benzotriazin-3-amine 1,4-dioxide |
4-Hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine SR 259075 SR 4233 Tirazone Win 59075 |
Tirazone |
Tirapazamine |
3-Aminobenzo[e][1,2,4]triazine 1,4-dioxide |